RARA CRAFT DATABASE for FDA Medical Devices
510(k)K202412

FDA DEVICE FACTS

ClearRT Helical kVCT for the Radixact Treatment Delivery System

Accuray Incorporated

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEDecember 18, 2020PRODUCT CODEIYE

Indications for use

The kVCT Imaging Feature is an option within the indicati ons for use of the Radixact Treatment Delivery System. The Radixact Tr eatment Delivery System is indicated for the delivery of radiation thera py, stereotactic radiotherapy or stereotactic radiosurgery to tumors or other targeted tissues anywhere in the body under the di rection of a licensed medical practitioner.

The intended use and indications for use st atements for the kVCT Imaging Feature (shown above) are the same as for the Radix act Treatment Delivery System (last cleared on K161146), except for the addition of the intro ductory sentence as kVCT Imaging is a type of Image Guided Radiotherapy (IGRT).

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026